Bio-Rad Laboratories's market cap is currently $8.03B. The company's EPS TTM is $2.61; its P/E ratio is 25.81; Bio-Rad Laboratories is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $1.95. See an overview of income statement, balance sheet, and cash flow financials.
